COIOSDeep risk insights through multi-disciplinary research across the globe
a close up of a rock surface with small cracks
Item new Peer-reviewed Added

A blood protein score of cellular ageing predicted death in UK Biobank

A blood protein score of cellular ageing, built in UK Biobank, predicted death and later dementia, COPD, heart attack and stroke, and changed over 18 months with exercise.

Researchers built a single score from blood proteins released by ageing cells, using a deep-learning model trained on UK Biobank proteomic data. The score predicted death and later dementia, COPD, myocardial infarction and stroke, independently of other risk factors. In a separate randomised trial, a multimodal exercise programme significantly changed the score's trajectory over 18 months.

Why it is interesting: Carries a measure of cellular ageing from a population cohort into a trial, where exercise moved it.

Source
Aging Cell, 1 October 2026
Paper
A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes
Authors
Zhao S, Kuo CL, Lenze EJ, Wetherell JL, Haynes L, El-Ahmad P et al.
DOI
10.1111/acel.70737
Type
Peer-reviewed article
Design
Semi-supervised deep-learning (guided autoencoder with transformer) proteomic score developed in UK Biobank Pharma Proteomics Project, externally validated in an independent randomised trial cohort with 18-month follow-up
Verdict
New finding
Driver
AI in medicine
Driver
Slowing ageing itself
Free full text
Free to read at the publisher
Attention
1 citation (Crossref) · as of 2026-11-18
Abstract — the authors' own words, CC BY

The accumulation of senescent cells is a recognized hallmark of biological aging and is associated with the onset of multiple chronic medical conditions. Senescent cells exhibit a distinct secretory profile, known as the senescence-associated secretory phenotype (SASP), which can propagate cellular senescence to neighboring and distant tissues. Measuring SASP factors in blood serves as a practical proxy for cellular senescence burden and may help track disease states and intervention outcomes. We developed and validated a composite SASP Score by integrating large-scale population proteomics data with a semi-supervised deep learning framework. The analytical workflow included: (1) selection of biologically curated SASP proteins; (2) development of a Guided autoencoder with Transformer (GAET) model using data from the UK Biobank Pharma Proteomics Project (UKB-PPP); (3) internal evaluation and association analyses within the UK Biobank; and (4) external validation and longitudinal assessment in an independent randomized clinical trial cohort. The deep learning-based SASP Score was a strong, independent predictor of mortality risk and incident serious, chronic medical conditions (e.g., dementia, COPD, myocardial infarction, stroke). In an independent cohort, multimodal exercise significantly changed the SASP Score trajectory over 18 months. Our findings support the potential of a deep learning-derived SASP Score as a biomarker for systemic cellular senescence burden. Our statistical approach can offer enhanced interpretability and cross-platform utility, providing a valuable tool for aging research and the evaluation of geroscience-guided interventions.

Other drivers in Data, models and systems